Dr. Lal PathLabs intimates a conference call on April 30, 2026, to discuss Q4 and FY26 financial results.
The call will be hosted by key management including Executive Chairman Dr. Arvind Lal and CEO Mr. Shankha Banerjee.
This is a regulatory disclosure pursuant to SEBI Listing Regulations (Regulation 30).